申请人:HOPPER Allen
公开号:US20080207660A1
公开(公告)日:2008-08-28
Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
选择性PDE4抑制是由芳基和杂环基吡唑化合物实现的。这些化合物与类似于罗利普兰的化合物相比,表现出更好的PDE4抑制作用,并且在抑制其他类别的PDE方面表现出选择性。